Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Th2 cytokine production pathway describes the cascade of molecular events and cellular differentiation that lead to the generation of Th2 cells, a subset of CD4+ T helper cells. Upon stimulation by cytokines, particularly interleukin-4 (IL-4), naïve CD4+ T cells differentiate into Th2 cells with the aid of antigen-presenting cells and transcription factors such as GATA3 and STAT6[2][3][6]. Mature Th2 cells secrete cytokines including IL-4, IL-5, and IL-13, which are essential in orchestrating humoral immunity, driving IgE class-switching in B cells, recruiting and activating eosinophils, and defending against helminth infections[2][5]. Dysregulation of this pathway contributes to the pathogenesis of allergic and type 2 inflammatory diseases, including asthma and atopic dermatitis. This pathway is targeted indirectly by drugs that block the activity of Th2 cytokines or their signaling receptors to manage such diseases[5][6].
Inhibition or neutralization of Th2 cytokines (IL-4, IL-5, IL-13) or their receptors Blockade of Th2 cell signaling and differentiation
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on T helper 2 cytokine production pathway.